<?xml version="1.0" encoding="UTF-8"?> <rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:wfw="http://wellformedweb.org/CommentAPI/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:creativeCommons="http://backend.userland.com/creativeCommonsRssModule" 	xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:media="http://search.yahoo.com/mrss/" ><channel><title>GenevaLunch &#187; Novartis</title> <atom:link href="http://genevalunch.com/blog/tag/novartis/feed/" rel="self" type="application/rss+xml" /><link>http://genevalunch.com</link> <description>Community Newspaper Online</description> <lastBuildDate>Sun, 27 May 2012 09:11:36 +0000</lastBuildDate> <language>en</language> <sy:updatePeriod>hourly</sy:updatePeriod> <sy:updateFrequency>1</sy:updateFrequency> <generator>http://wordpress.org/?v=3.3.1</generator> <creativeCommons:license>http://creativecommons.org/licenses/by-nc-nd/3.0/</creativeCommons:license> <copyright>Copyright &#xA9; GenevaLunch 2010 </copyright> <managingEditor>editor@genevalunch.com (GenevaLunch)</managingEditor> <webMaster>editor@genevalunch.com (GenevaLunch)</webMaster> <image> <url>http://genevalunch.com/wp-content/plugins/podpress/images/powered_by_podpress.jpg</url><title>GenevaLunch</title><link>http://genevalunch.com</link> <width>144</width> <height>144</height> </image> <itunes:subtitle></itunes:subtitle> <itunes:summary>Community Newspaper Online</itunes:summary> <itunes:keywords></itunes:keywords> <itunes:category text="Society &#38; Culture" /> <itunes:author>GenevaLunch</itunes:author> <itunes:owner> <itunes:name>GenevaLunch</itunes:name> <itunes:email>editor@genevalunch.com</itunes:email> </itunes:owner> <itunes:block>no</itunes:block> <itunes:explicit>no</itunes:explicit> <itunes:image href="http://genevalunch.com/wp-content/plugins/podpress/images/powered_by_podpress_large.jpg" /> <item><title>Novartis jumps from Prangins shutdown plans to Zurich area growth</title><link>http://genevalunch.com/blog/2012/04/23/novartis-jumps-from-prangins-shutdown-plans-to-zurich-area-growth/</link> <comments>http://genevalunch.com/blog/2012/04/23/novartis-jumps-from-prangins-shutdown-plans-to-zurich-area-growth/#comments</comments> <pubDate>Mon, 23 Apr 2012 17:03:48 +0000</pubDate> <dc:creator>Ellen Wallace</dc:creator> <category><![CDATA[Business]]></category> <category><![CDATA[News]]></category> <category><![CDATA[drugs]]></category> <category><![CDATA[expansion]]></category> <category><![CDATA[new projects]]></category> <category><![CDATA[Novartis]]></category> <category><![CDATA[Nyon]]></category> <category><![CDATA[pharmaceuticals]]></category> <category><![CDATA[Prangins]]></category> <category><![CDATA[Stein]]></category> <category><![CDATA[Switzerland]]></category> <category><![CDATA[Zurich]]></category><guid isPermaLink="false">http://genevalunch.com/?p=69400</guid> <description><![CDATA[<p><a href="http://genevalunch.com/blog/2012/04/23/novartis-jumps-from-prangins-shutdown-plans-to-zurich-area-growth/">GenevaLunch.com</a> Five months ago the company was cutting jobs; today it is expanding its Swiss base BASEL / GENEVA, SWITZERLAND &#8211; Novartis is pumping CHF500 million into a new plant in Stein, canton Aargau, near Zurich, to replace an older one with a state of the art production facility. Stein will become a platform for launching [...]</p><p><small><a href="http://genevalunch.com/blog/2012/04/23/novartis-jumps-from-prangins-shutdown-plans-to-zurich-area-growth/">Novartis jumps from Prangins shutdown plans to Zurich area growth</a> &copy; <a href="http://genevalunch.com" rel="cc:attributionURL">genevalunch.com</a>, <a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/">Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported</a>.</small></p>]]></description> <wfw:commentRss>http://genevalunch.com/blog/2012/04/23/novartis-jumps-from-prangins-shutdown-plans-to-zurich-area-growth/feed/</wfw:commentRss> <slash:comments>0</slash:comments> </item> <item><title>Swiss open new research centre in Singapore</title><link>http://genevalunch.com/blog/2012/03/14/swiss-open-new-research-centre-in-singapore/</link> <comments>http://genevalunch.com/blog/2012/03/14/swiss-open-new-research-centre-in-singapore/#comments</comments> <pubDate>Wed, 14 Mar 2012 09:35:07 +0000</pubDate> <dc:creator>Ellen Wallace</dc:creator> <category><![CDATA[News]]></category> <category><![CDATA[Tech/media]]></category> <category><![CDATA[Alain Berset]]></category> <category><![CDATA[biotechnology]]></category> <category><![CDATA[Novartis]]></category> <category><![CDATA[research]]></category> <category><![CDATA[Singapore]]></category> <category><![CDATA[Singapore-ETH Centre for Global Environmental Sustainability (SEC)]]></category> <category><![CDATA[Swiss]]></category> <category><![CDATA[Zurich]]></category><guid isPermaLink="false">http://genevalunch.com/?p=67613</guid> <description><![CDATA[<p><a href="http://genevalunch.com/blog/2012/03/14/swiss-open-new-research-centre-in-singapore/">GenevaLunch.com</a> BERN, SWITZERLAND &#8211; The official inauguration of Switzerland&#8217;s first university research centre in Asia takes place Friday 16 March in Singapore. The Singapore-ETH Centre for Global Environmental Sustainability (SEC) was created by Zurich&#8217;s federal polytechnic institute ETH in September 2010 with financial support from the National Research Foundation (NRF) of Singapore. The first research programme [...]</p><p><small><a href="http://genevalunch.com/blog/2012/03/14/swiss-open-new-research-centre-in-singapore/">Swiss open new research centre in Singapore</a> &copy; <a href="http://genevalunch.com" rel="cc:attributionURL">genevalunch.com</a>, <a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/">Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported</a>.</small></p>]]></description> <wfw:commentRss>http://genevalunch.com/blog/2012/03/14/swiss-open-new-research-centre-in-singapore/feed/</wfw:commentRss> <slash:comments>0</slash:comments> </item> <item><title>Novartis&#8217;s Prangins site to remain open</title><link>http://genevalunch.com/blog/2012/01/17/novartiss-prangins-site-to-remain-open/</link> <comments>http://genevalunch.com/blog/2012/01/17/novartiss-prangins-site-to-remain-open/#comments</comments> <pubDate>Tue, 17 Jan 2012 14:25:20 +0000</pubDate> <dc:creator>Ellen Wallace</dc:creator> <category><![CDATA[Business]]></category> <category><![CDATA[News]]></category> <category><![CDATA[closing]]></category> <category><![CDATA[cut]]></category> <category><![CDATA[deal reached]]></category> <category><![CDATA[jobs]]></category> <category><![CDATA[negotiations]]></category> <category><![CDATA[Novartis]]></category> <category><![CDATA[plant]]></category> <category><![CDATA[Prangins]]></category><guid isPermaLink="false">http://genevalunch.com/?p=65362</guid> <description><![CDATA[<p><a href="http://genevalunch.com/blog/2012/01/17/novartiss-prangins-site-to-remain-open/">GenevaLunch.com</a> NYON, SWITZERLAND &#8211; Novartis will not close its Prangin site and all jobs there will be saved, the company will be investing more money in the plant, canton Vaud will give the company a tax break and some of the unused space will be developed into housing. Tough talks between Novartis workers and managers, the [...]</p><p><small><a href="http://genevalunch.com/blog/2012/01/17/novartiss-prangins-site-to-remain-open/">Novartis&#8217;s Prangins site to remain open</a> &copy; <a href="http://genevalunch.com" rel="cc:attributionURL">genevalunch.com</a>, <a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/">Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported</a>.</small></p>]]></description> <wfw:commentRss>http://genevalunch.com/blog/2012/01/17/novartiss-prangins-site-to-remain-open/feed/</wfw:commentRss> <slash:comments>0</slash:comments> </item> <item><title>Novartis 2,000 job cuts in US result of patent ending, new drug demand fall</title><link>http://genevalunch.com/blog/2012/01/13/novartis-1600-job-cuts-in-us-result-of-patent-ending/</link> <comments>http://genevalunch.com/blog/2012/01/13/novartis-1600-job-cuts-in-us-result-of-patent-ending/#comments</comments> <pubDate>Fri, 13 Jan 2012 10:48:05 +0000</pubDate> <dc:creator>Ellen Wallace</dc:creator> <category><![CDATA[Business]]></category> <category><![CDATA[News]]></category> <category><![CDATA[administrative jobs]]></category> <category><![CDATA[Altitude trials]]></category> <category><![CDATA[clinical trials]]></category> <category><![CDATA[Diovan (valsartan)]]></category> <category><![CDATA[drugs]]></category> <category><![CDATA[jobs cut]]></category> <category><![CDATA[layoffs]]></category> <category><![CDATA[New Jersey]]></category> <category><![CDATA[Novartis]]></category> <category><![CDATA[patents]]></category> <category><![CDATA[Rasilez/Tekturna]]></category> <category><![CDATA[sales force]]></category> <category><![CDATA[USA]]></category><guid isPermaLink="false">http://genevalunch.com/?p=65219</guid> <description><![CDATA[<p><a href="http://genevalunch.com/blog/2012/01/13/novartis-1600-job-cuts-in-us-result-of-patent-ending/">GenevaLunch.com</a> BASEL, SWITZERLAND &#8211; Novartis will be cutting close to 2,000 jobs in the US, in New Jersey, as the result of an expected fall in demand for a relatively new medicine and the expiry of the patent for another, the company announced Friday 13 January in Basel. The sales force will lose 1,630 jobs and [...]</p><p><small><a href="http://genevalunch.com/blog/2012/01/13/novartis-1600-job-cuts-in-us-result-of-patent-ending/">Novartis 2,000 job cuts in US result of patent ending, new drug demand fall</a> &copy; <a href="http://genevalunch.com" rel="cc:attributionURL">genevalunch.com</a>, <a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/">Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported</a>.</small></p>]]></description> <wfw:commentRss>http://genevalunch.com/blog/2012/01/13/novartis-1600-job-cuts-in-us-result-of-patent-ending/feed/</wfw:commentRss> <slash:comments>0</slash:comments> </item> <item><title>Strikes and protests in Geneva area: Hug calls for calm, Novartis boss visits</title><link>http://genevalunch.com/blog/2011/11/19/strikes-and-protests-in-geneva-area-hug-calls-for-calm-novartis-boss-visits/</link> <comments>http://genevalunch.com/blog/2011/11/19/strikes-and-protests-in-geneva-area-hug-calls-for-calm-novartis-boss-visits/#comments</comments> <pubDate>Sat, 19 Nov 2011 09:15:09 +0000</pubDate> <dc:creator>Ellen Wallace</dc:creator> <category><![CDATA[Business]]></category> <category><![CDATA[News]]></category> <category><![CDATA[CEO]]></category> <category><![CDATA[Geneva]]></category> <category><![CDATA[HUG]]></category> <category><![CDATA[Joe Jimenez]]></category> <category><![CDATA[lab workers]]></category> <category><![CDATA[Novartis]]></category> <category><![CDATA[Nyon]]></category> <category><![CDATA[Prangins]]></category> <category><![CDATA[strikes]]></category> <category><![CDATA[unions]]></category> <category><![CDATA[university hospitals]]></category><guid isPermaLink="false">http://genevalunch.com/?p=63700</guid> <description><![CDATA[<p><a href="http://genevalunch.com/blog/2011/11/19/strikes-and-protests-in-geneva-area-hug-calls-for-calm-novartis-boss-visits/">GenevaLunch.com</a> GENEVA, SWITZERLAND &#8211; The Hug university hospitals in Geneva late Friday pleaded for everyone involved in its lab workers strike to get the situation back to normal, in the wake of the cantonal council&#8217;s announcement Thursday that it will not intervene. At issue: work conditions but also a review of the division of labour. The [...]</p><p><small><a href="http://genevalunch.com/blog/2011/11/19/strikes-and-protests-in-geneva-area-hug-calls-for-calm-novartis-boss-visits/">Strikes and protests in Geneva area: Hug calls for calm, Novartis boss visits</a> &copy; <a href="http://genevalunch.com" rel="cc:attributionURL">genevalunch.com</a>, <a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/">Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported</a>.</small></p>]]></description> <wfw:commentRss>http://genevalunch.com/blog/2011/11/19/strikes-and-protests-in-geneva-area-hug-calls-for-calm-novartis-boss-visits/feed/</wfw:commentRss> <slash:comments>0</slash:comments> </item> <item><title>Novartis employees in Prangins protest, firm uses numbers to explain closing</title><link>http://genevalunch.com/blog/2011/11/04/novartis-employees-in-prangins-protest-firm-uses-numbers-to-explain-closing/</link> <comments>http://genevalunch.com/blog/2011/11/04/novartis-employees-in-prangins-protest-firm-uses-numbers-to-explain-closing/#comments</comments> <pubDate>Fri, 04 Nov 2011 05:47:46 +0000</pubDate> <dc:creator>Ellen Wallace</dc:creator> <category><![CDATA[Business]]></category> <category><![CDATA[News]]></category> <category><![CDATA[closure]]></category> <category><![CDATA[Geneva]]></category> <category><![CDATA[Lausanne]]></category> <category><![CDATA[Novartis]]></category> <category><![CDATA[Nyon]]></category> <category><![CDATA[Prangins plant]]></category> <category><![CDATA[Vaud]]></category><guid isPermaLink="false">http://genevalunch.com/?p=63215</guid> <description><![CDATA[<p><a href="http://genevalunch.com/blog/2011/11/04/novartis-employees-in-prangins-protest-firm-uses-numbers-to-explain-closing/">GenevaLunch.com</a> LAUSANNE / NYON, SWITZERLAND &#8211; Novartis plans to close its centre in Prangins, next to Nyon, have sparked protests by employees since the news was announced 27 October, and a new protest is planned in Nyon Friday afternoon. The company now says it sending in an expert from the US next week to explain an [...]</p><p><small><a href="http://genevalunch.com/blog/2011/11/04/novartis-employees-in-prangins-protest-firm-uses-numbers-to-explain-closing/">Novartis employees in Prangins protest, firm uses numbers to explain closing</a> &copy; <a href="http://genevalunch.com" rel="cc:attributionURL">genevalunch.com</a>, <a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/">Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported</a>.</small></p>]]></description> <wfw:commentRss>http://genevalunch.com/blog/2011/11/04/novartis-employees-in-prangins-protest-firm-uses-numbers-to-explain-closing/feed/</wfw:commentRss> <slash:comments>0</slash:comments> </item> <item><title>Novartis to close Nyon site, 1100 jobs to go in Switzerland</title><link>http://genevalunch.com/blog/2011/10/25/novartis-to-close-nyon-site-1100-jobs-to-go-in-switzerland/</link> <comments>http://genevalunch.com/blog/2011/10/25/novartis-to-close-nyon-site-1100-jobs-to-go-in-switzerland/#comments</comments> <pubDate>Tue, 25 Oct 2011 07:38:33 +0000</pubDate> <dc:creator>Ellen Wallace</dc:creator> <category><![CDATA[Business]]></category> <category><![CDATA[News]]></category> <category><![CDATA[Basel]]></category> <category><![CDATA[dollar]]></category> <category><![CDATA[financial results]]></category> <category><![CDATA[impact]]></category> <category><![CDATA[jobs lost]]></category> <category><![CDATA[Novartis]]></category> <category><![CDATA[Nyon]]></category> <category><![CDATA[pharmaceuticals]]></category> <category><![CDATA[Swiss franc]]></category> <category><![CDATA[U.S.]]></category><guid isPermaLink="false">http://genevalunch.com/?p=62814</guid> <description><![CDATA[<p><a href="http://genevalunch.com/blog/2011/10/25/novartis-to-close-nyon-site-1100-jobs-to-go-in-switzerland/">GenevaLunch.com</a> NYON, SWITZERLAND &#8211; Pharmaceutical company Novartis is closing its site in Nyon as part of a restructuration that will involve eliminating 1,100 jobs in Switzerland. The company is cutting a total of 2,000 jobs, with most of the rest in the US. The Nyon site employs 320 persons and 770 jobs will also go in [...]</p><p><small><a href="http://genevalunch.com/blog/2011/10/25/novartis-to-close-nyon-site-1100-jobs-to-go-in-switzerland/">Novartis to close Nyon site, 1100 jobs to go in Switzerland</a> &copy; <a href="http://genevalunch.com" rel="cc:attributionURL">genevalunch.com</a>, <a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/">Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported</a>.</small></p>]]></description> <wfw:commentRss>http://genevalunch.com/blog/2011/10/25/novartis-to-close-nyon-site-1100-jobs-to-go-in-switzerland/feed/</wfw:commentRss> <slash:comments>1</slash:comments> </item> <item><title>Swiss business news highlights 20 July: pharma, oil spill, media</title><link>http://genevalunch.com/blog/2011/07/20/swiss-business-news-highlights-20-july-pharma-oil-spill-media/</link> <comments>http://genevalunch.com/blog/2011/07/20/swiss-business-news-highlights-20-july-pharma-oil-spill-media/#comments</comments> <pubDate>Wed, 20 Jul 2011 11:48:49 +0000</pubDate> <dc:creator>Ellen Wallace</dc:creator> <category><![CDATA[Business]]></category> <category><![CDATA[News]]></category> <category><![CDATA[advertising online]]></category> <category><![CDATA[dailies]]></category> <category><![CDATA[EPFL]]></category> <category><![CDATA[financial press]]></category> <category><![CDATA[market]]></category> <category><![CDATA[newspapers]]></category> <category><![CDATA[Novartis]]></category> <category><![CDATA[Remp]]></category> <category><![CDATA[Roche]]></category> <category><![CDATA[statistics]]></category> <category><![CDATA[Swiss media]]></category> <category><![CDATA[Swiss pharmaceuticals]]></category><guid isPermaLink="false">http://genevalunch.com/?p=59998</guid> <description><![CDATA[<p><a href="http://genevalunch.com/blog/2011/07/20/swiss-business-news-highlights-20-july-pharma-oil-spill-media/">GenevaLunch.com</a> GENEVA, SWITZERLAND &#8211; GenevaLunch is on a slow-news holiday schedule for the next two weeks, but to make sure you don&#8217;t miss key reports we&#8217;re bringing you highlights from some of the news beats, with links to original sources: EPFL plays key role in understanding Deepwater Horizon oil spill EPFL is playing a key role [...]</p><p><small><a href="http://genevalunch.com/blog/2011/07/20/swiss-business-news-highlights-20-july-pharma-oil-spill-media/">Swiss business news highlights 20 July: pharma, oil spill, media</a> &copy; <a href="http://genevalunch.com" rel="cc:attributionURL">genevalunch.com</a>, <a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/">Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported</a>.</small></p>]]></description> <wfw:commentRss>http://genevalunch.com/blog/2011/07/20/swiss-business-news-highlights-20-july-pharma-oil-spill-media/feed/</wfw:commentRss> <slash:comments>0</slash:comments> </item> <item><title>Novartis profits and mgmt. pay up, but future warnings</title><link>http://genevalunch.com/blog/2011/01/27/novartis-profits-and-mgmt-pay-up-but-future-warnings/</link> <comments>http://genevalunch.com/blog/2011/01/27/novartis-profits-and-mgmt-pay-up-but-future-warnings/#comments</comments> <pubDate>Thu, 27 Jan 2011 10:49:51 +0000</pubDate> <dc:creator>Ellen Wallace</dc:creator> <category><![CDATA[Business]]></category> <category><![CDATA[News]]></category> <category><![CDATA[2010]]></category> <category><![CDATA[annual report]]></category> <category><![CDATA[Health]]></category> <category><![CDATA[Jose Jiminez]]></category> <category><![CDATA[Novartis]]></category> <category><![CDATA[pharmaceuticals]]></category> <category><![CDATA[profits]]></category> <category><![CDATA[salaries]]></category> <category><![CDATA[sales]]></category> <category><![CDATA[vaccines]]></category><guid isPermaLink="false">http://genevalunch.com/?p=52918</guid> <description><![CDATA[<p><a href="http://genevalunch.com/blog/2011/01/27/novartis-profits-and-mgmt-pay-up-but-future-warnings/">GenevaLunch.com</a> Basel, Switzerland (GenevaLunch) &#8211; Swiss residents could be forgiven for wondering if Novartis is in relatively good or bad shape Thursday morning, depending on which news sources they follow. The company&#8217;s annual report, published Thursday 27 January, shows net sales of $50.6 billion, up from $44.3b a year earlier. Net income was close to $10b, [...]</p><p><small><a href="http://genevalunch.com/blog/2011/01/27/novartis-profits-and-mgmt-pay-up-but-future-warnings/">Novartis profits and mgmt. pay up, but future warnings</a> &copy; <a href="http://genevalunch.com" rel="cc:attributionURL">genevalunch.com</a>, <a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/">Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported</a>.</small></p>]]></description> <wfw:commentRss>http://genevalunch.com/blog/2011/01/27/novartis-profits-and-mgmt-pay-up-but-future-warnings/feed/</wfw:commentRss> <slash:comments>0</slash:comments> </item> <item><title>Novartis settles sex discrimination suit; quarterly sales up</title><link>http://genevalunch.com/blog/2010/07/15/novartis-settles-sex-discrimination-suit-quarterly-sales-up/</link> <comments>http://genevalunch.com/blog/2010/07/15/novartis-settles-sex-discrimination-suit-quarterly-sales-up/#comments</comments> <pubDate>Thu, 15 Jul 2010 08:14:50 +0000</pubDate> <dc:creator>Ellen Wallace</dc:creator> <category><![CDATA[Business]]></category> <category><![CDATA[News]]></category> <category><![CDATA[lawsuit settled]]></category> <category><![CDATA[Novartis]]></category> <category><![CDATA[sales]]></category> <category><![CDATA[second quarter 2010]]></category> <category><![CDATA[sex discrimination]]></category><guid isPermaLink="false">http://genevalunch.com/?p=44939</guid> <description><![CDATA[<p><a href="http://genevalunch.com/blog/2010/07/15/novartis-settles-sex-discrimination-suit-quarterly-sales-up/">GenevaLunch.com</a> Basel, Switzerland (GenevaLunch.com) - Pharmaceutical company Novartis and a group of former and current employees who charged the company with sex discrimination have settled the case amicably, the company announced 14 July. It will pay up to $152.5 million in back-pay and compensatory damages to eligible individuals and it has agreed to spend $52.5m over [...]</p><p><small><a href="http://genevalunch.com/blog/2010/07/15/novartis-settles-sex-discrimination-suit-quarterly-sales-up/">Novartis settles sex discrimination suit; quarterly sales up</a> &copy; <a href="http://genevalunch.com" rel="cc:attributionURL">genevalunch.com</a>, <a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/">Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported</a>.</small></p>]]></description> <wfw:commentRss>http://genevalunch.com/blog/2010/07/15/novartis-settles-sex-discrimination-suit-quarterly-sales-up/feed/</wfw:commentRss> <slash:comments>0</slash:comments> </item> </channel> </rss>
<!-- Performance optimized by W3 Total Cache. Learn more: http://www.w3-edge.com/wordpress-plugins/

Minified using disk: basic
Page Caching using disk: enhanced

Served from: www.genevalunch.com @ 2012-05-27 14:37:53 -->
